Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 337 - 344 of 11616 results
Telephone and Texting Compliance News: Regulatory Update — FCC Announces Meeting of the North American Numbering Council
June 28, 2024| Article| Viewpoint
Telephone and Texting Compliance News: Litigation Update — Fourth Circuit Adds to TCPA Case Law at Appellate and District Court Levels
June 28, 2024| Article| Viewpoint
New York State Now Requires Paid Lactation Breaks
June 28, 2024| Blog| Viewpoint
Supreme Court in Jarkesy Limits the SEC’s Powers to Use In-House Administrative Courts
June 28, 2024| Blog| Viewpoint
Telephone and Texting Compliance News — June 2024
June 28, 2024| Article| Viewpoint
Implementing AI: Practical Steps for Advisers and Broker-Dealers Deploying AI Compliance Tools Amidst Regulatory Uncertainty
June 27, 2024| Webinar| Viewpoint
Colorado AI Systems Regulation: What Health Care Deployers and Developers Need to Know
June 27, 2024| Blog| Viewpoint
Protecting Trade Secrets In US, EU Gov't Agency Submissions
June 26, 2024| News
News & Press Releases
Mintz Announces New Members
December 20, 2024
Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.
Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.
Dealmaking Dormant No More
December 17, 2024
International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.